TRV GP Vi, LLC

In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 9, 2025), TRV GP Vi, LLC reported 4 stock positions worth $42.0 million. Its top holding was Septerna (SEPN) at 58.1% of the portfolio, followed by Rapport Therapeutics (RAPP, 23.2%) and Cargo Therapeutics (CRGX, 18.1%). Compared with Q4 2024, it added to 1. The biggest buy was Septerna (SEPN, shares +34%).

Most Recent 13F
Q2 2026
Location
Boston, MA
CIK
0001990716
Portfolio Value
$42.0M (Q1 2025)
SEC Filing
0000950123-25-004484 ↗ filed May 9, 2025

Holdings Value

0$50.0M$100.0M$150.0M$200.0M$250.0M Q4 2024: $116.9M Q4 2024 Q1 2025: $42.0M $42.0M Q1 2025 Q2 2025: $64.2M Q2 2025 Q3 2025: $109.6M Q3 2025 Q4 2025: $148.5M Q4 2025 Q1 2026: $135.6M Q1 2026 Q2 2026: $232.3M Q2 2026

Holdings 4 stocks · $42.0M
SEPN Septerna Inc. 58.10% 4,211,659 $24.4M Add +33.6%
RAPP Rapport Therapeutics Inc. 23.16% 969,218 $9.7M No change
CRGX Cargo Therapeutics Inc. 18.11% 1,867,119 $7.6M No change
TNGX Tango Therapeutics Inc. 0.63% 194,174 $266K No change

Portfolio Sells Q4 2024 → Q1 2025
None this quarter.

Portfolio Buys Q4 2024 → Q1 2025
SEPN Septerna Inc. Add +33.6% 58.10% −3.65

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 4$232.3MSEPN, SPTX, RAPP, TNGX
Q1 2026 3$135.6MSEPN, RAPP, TNGX
Q4 2025 3$148.5MSEPN, RAPP, TNGX
Q3 2025 3$109.6MSEPN, RAPP, TNGX
Q2 2025 4$64.2MSEPN, RAPP, CRGX, TNGX
Q1 2025 4$42.0MSEPN, RAPP, CRGX, TNGX
Q4 2024 4$116.9MSEPN, CRGX, RAPP, TNGX